Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

February 29, 2000

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

oxaliplatin

Trial Locations (11)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

10021

Memorial Sloan-Kettering Cancer Center, New York

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

15213

University of Pittsburgh Cancer Institute, Pittsburgh

48201

Barbara Ann Karmanos Cancer Institute, Detroit

53792

University of Wisconsin Comprehensive Cancer Center, Madison

91010

Beckman Research Institute, City of Hope, Los Angeles

95817

University of California Davis Cancer Center, Sacramento

90033-0800

USC/Norris Comprehensive Cancer Center, Los Angeles

20307-5000

Walter Reed Army Medical Center, Washington D.C.

44106-5065

Ireland Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00005077 - Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction | Biotech Hunter | Biotech Hunter